首页> 外国专利> A pharmaceutical compositon containing SkullcapflavoneⅡ or pharmaceutically acceptable salt thereof for the prevention or treatment of asthma

A pharmaceutical compositon containing SkullcapflavoneⅡ or pharmaceutically acceptable salt thereof for the prevention or treatment of asthma

机译:含有骷髅黄酮Ⅱ或其药学上可接受的盐的药物组合物,用于预防或治疗哮喘

摘要

The present invention is effective acceptable salt or a pharmaceutically Skull Cop isoflavones It relates to a pharmaceutical composition for the prevention or treatment of asthma containing a component, specifically a skull Cobb flavone compound which inhibits weight loss caused by asthma, and can alleviate the airway hypersensitivity, serum, BAL liquid within the IgE, ovalbumin-specific IgE, interleukin-4, 5, 13, and MMP-9 production of collagen erosion around the trachea, it is possible to inhibit bronchial inflammatory cell infiltration and mucus secretion in the bronchial only have low liver toxicity as well, and further, reduce the concentration of TGF-1, Smad7 is expressed to be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of bronchial asthma by inhibiting the growth and pSmad2 / 3 levels. ;
机译:本发明是有效的可接受的盐或药学上可接受的头骨警察异黄酮。本发明涉及用于预防或治疗哮喘的药物组合物,所述药物组合物包含抑制哮喘引起的体重减轻并可以减轻气道超敏性的成分,特别是头骨Cobb黄酮化合物。 ,血清,IgE内的BAL液,卵清蛋白特异性IgE,白介素4、5、13和MMP-9产生气管周围胶原蛋白糜烂,仅在支气管中可能抑制支气管炎性细胞浸润和粘液分泌Smad7还具有较低的肝毒性,并且还降低了TGF-1的浓度,因此可通过抑制生长和pSmad2 / 3的水平用作预防或治疗支气管哮喘的药物组合物的有效成分。 ;

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号